Evidence map›Paper›PMID 35492962›Full record

ReviewThe Lancet regional health. Europe2022

Targeted screening in the UK: A narrow concept with broad application.

Anna Bobrowska, Molly Murton, Farah Seedat, Cristina Visintin, Anne Mackie, Robert Steele, John Marshall

Abstract readReview
In one paragraph

Review in The Lancet regional health. Europe, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Artificial intelligence for cancer screening and surveillance.ESMO real world data and digital oncology · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Anna BobrowskaCostello Medical, 50/60 Station Road, Cambridge CB1 2JH, UK.
Molly MurtonCostello Medical, 50/60 Station Road, Cambridge CB1 2JH, UK.
Farah SeedatUK National Screening Committee, Southside, 39 Victoria Street, London SW1H 0EU, UK.
Cristina VisintinUK National Screening Committee, Southside, 39 Victoria Street, London SW1H 0EU, UK.
Anne MackieUK National Screening Committee, Southside, 39 Victoria Street, London SW1H 0EU, UK.
Robert SteeleUK National Screening Committee, Southside, 39 Victoria Street, London SW1H 0EU, UK.
John MarshallUK National Screening Committee, Southside, 39 Victoria Street, London SW1H 0EU, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A recent report on screening in the UK proposed that the responsibility for recommendations on population and targeted screening programmes should be held by one new integrated advisory body. There is no wide international consensus on the definition of targeted screening. Our review identified and compared the defining components of screening terms: targeted, population, selective, and cascade screening, and case finding. Definitions of targeted screening and population screening were clearly demarcated by the eligible population; targeted and selective screening were found to be conceptually interchangeable; cascade screening, whilst conceptually similar to targeted screening across several components, was only used within the context of genetic diseases. There was little consensus between different definitions of case finding. These comparisons contributed to an updated definition of targeted screening. Considerable overlap between definition components across terms implies that a broad range of disease areas may fall into the remit of the new advisory body.

Indexed as

Cascade screeningCase findingPopulation screeningScreeningSelective screeningTargeted screening

Identifiers

PMID35492962
PMCPMC9038565

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.